Diabetes & Endocrine Disorders

A Wealth of Experience

We have collaborated with our clients on projects to research diabetes and endocrine disorders, diabetes and endocrine treatments, and complications and comorbidities of diabetes and endocrine disorders. Our experience includes:

  • Type I diabetes
  • Type 2 diabetes
  • Microvascular complications in diabetes including:
    • Diabetic retinopathy
    • Diabetic nephropathy
    • Peripheral neuropathy
  • Macrovascular complications including:
    • Cardiovascular events related to diabetes
    • Peripheral vascular disease
    • Diabetic foot ulcers
  • Obesity

Types of Projects

We have implemented studies to help our clients develop strategies in the diabetes market and to develop and gain market access for products to treat diabetes and endocrine disorders and complications arising from treatment of diabetes. Recent projects have included:

Our Experts

Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Colleen Castro
Senior Associate, Market Access and Outcomes Strategy
Christine Poulos
Senior Economist and Head, Health Preference Assessment
Katherine Hicks
Director, Health Economics
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Catherine Masaquel
Senior Director, Market Access and Outcomes Strategy
Alicia Gilsenan
Senior Director and Head, Epidemiology
Manel Pladevall-Vila
Senior Director, Epidemiology
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Katherine Stull
Director, Health Economics
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Sean Candrilli
Vice President, Health Economics
Patricia Sacco
Executive Director, Surveys and Observational Studies
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Lauren Nelson
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Juliana Meyers
Director, Health Economics
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Bintu Sherif
Director, Biostatistics
Lia Gutierrez
Senior Director, Epidemiology
Will Herring
Senior Director, Health Economics
Mary Anthony
Senior Director, Epidemiology
Caroline Ling
Senior Director and HTA Specialist, Market Access and Outcomes Strategy
Andrea Margulis
Director, Epidemiology
Annete Njue
Director, Market Access and Outcomes Strategy
Emma Hawe
Head, Data Analytics and Design Strategy
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Keith Davis
Senior Director, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Carol Mansfield
Senior Economist and Head, Health Preference Assessment
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Costel Chirila
Director, Biostatistics
Michele Wilson
Senior Director, Health Economic

Selected Recent Diabetes & Endocrine Disorders Publications

Zhou CK, Dinh J, Danysh HE, Johannes C, Gutierrez L, Schmid R, Arana A, Kaye JA, Pladevall-Vila M, Garcia-Albeniz X, Gangemi K, Yin R, Ruzafa JC, Gilsenan A, Beachler DC. Validity of claims-based algorithms to identify acute kidney injury, acute liver injury, severe complications of urinary tract infections, breast cancer, and bladder cancer among patients with type 2 diabetes: a pilot study. Poster presented at the 35th Annual ICPE Conference; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):317. doi: 10.1002/pds.4864.